RPRX: Royalty Pharma plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 13,714.73
Enterprise Value ($M) 23,793.92
Book Value ($M) 10,258.47
Book Value / Share 23.67
Price / Book 1.34
NCAV ($M) -6,078.21
NCAV / Share -14.03
Price / NCAV -2.26

Profitability (mra)
Return on Invested Capital (ROIC) 0.05
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.09

Liquidity (mrq)
Quick Ratio 1.44
Current Ratio 1.44

Balance Sheet (mrq) ($M)
Current Assets 1,802.14
Assets 18,222.72
Liabilities 7,880.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,263.00
Operating Income 1,292.00
Net Income 859.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2,769.00
Cash from Investing -2,678.00
Cash from Financing 361.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-21 13D/A Severgnini Achille G. 8.30 -13.56
02-12 13G/A Fmr Llc 5.90 -16.70
02-04 13G BlackRock, Inc. 5.70
11-08 13G/A Morgan Stanley 8.20 -11.28

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-28 900,476 3,242,452 27.77
2025-03-27 2,712,633 6,641,679 40.84
2025-03-25 716,570 3,890,310 18.42
2025-03-24 355,210 1,574,277 22.56

(click for more detail)

Similar Companies
RLMD – Relmada Therapeutics, Inc. RLYB – Rallybio Corporation
ROIV – Roivant Sciences Ltd. RPTX – Repare Therapeutics Inc.
RVMD – Revolution Medicines, Inc.


Financial data and stock pages provided by
Fintel.io